Thailand Peptides
Catalog
Research
Calculator
Get in Contact
Comparison · Cognitive & Nootropic

DSIP vs Selank

DSIP and Selank solve different nighttime-and-daytime problems. DSIP targets sleep architecture and is investigated for sleep quality and chronic-pain modulation. Selank is an anxiolytic daytime nootropic that modulates anxiety and stress without sedation.

Bangkok research desk ·

Side-by-side

DSIP Selank
MechanismDelta-sleep-inducing nonapeptide; sleep architecture modulation.Tuftsin analog; anxiolytic via enkephalin and GABAergic modulation.
Half-lifeShort.Short (intranasal).
Dose100-200 mcg nightly SC.250-500 mcg × 2 daily intranasal.
CycleAs-needed ongoing use.14 days on / 14 off.
Research contextSleep quality and chronic-pain modulation; mechanism unresolved1.Anxiolytic; modulates hippocampal transcriptome2.
Cost tierLow.Low-to-mid.

DSIP and Selank occupy non-overlapping niches in the cognitive and recovery research literature. DSIP was originally isolated from rabbit cerebrospinal fluid and is investigated for sleep architecture and chronic-pain modulation1. Its exact mechanism remains unresolved despite decades of research; the functional effect is a modulation of sleep patterns and pain perception, but the receptor target is not definitively mapped.

Selank is a tuftsin analog, administered intranasally, with a cleaner characterised mechanism via enkephalinergic and GABAergic modulation2. Its use is daytime anxiolytic and stress-resilience. Subjects describe reduced anxiety without the sedation that typically accompanies GABAergic agents, which is the feature that distinguishes Selank from benzodiazepines as a research comparator.

In research protocols, the two are often used in sequence rather than comparison: Selank during the day for stress resilience, DSIP at night for sleep-quality effects. Both have limited clinical data relative to the broader pharmaceutical literature, and research should account for the mechanistic ambiguity of DSIP in particular. See the best peptides for sleep and recovery and nootropic peptide mechanisms for the broader context.

Frequently asked

Can DSIP and Selank be used together?
Yes, and the common pattern is sequential: Selank during the day, DSIP at night. Mechanisms do not overlap and administration routes differ (intranasal vs subcutaneous).
Is DSIP a sleep aid?
It is investigated as one, but the clinical evidence is limited and the mechanism is incompletely characterised1. Research use for sleep-architecture modulation is ongoing.
Which has more human data?
Selank has more contemporary research activity and clearer mechanistic characterisation. DSIP has a longer research history but less modern trial data.
Research desk
Ordering both DSIP and Selank for a research protocol? The Bangkok desk handles pricing, COA, and timing on WhatsApp.
Open a line with the research desk ≥98% HPLC purity · supplier COA on file · Bangkok-based

Go deeper

Related comparisons

References

  1. Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006. PMID: 16539679
  2. Kolomin T, et al. Transcriptomic response of rat hippocampus and spleen cells to Selank. Dokl Biochem Biophys. 2010. PMID: 20380151

All references verified against PubMed via NCBI E-utilities.